Novo Nordisk Shares Climb on Dual Tailwinds, but Data Gaps and Cost Concerns Keep Bulls in Check
Novo Nordisk’s stock has clawed back ground from its March lows, powered by two distinct catalysts: a newly…
Novo Nordisk Shares Face Pressure Amid Pricing Concerns and Analyst Caution
Novo Nordisk shares fall as US pricing deal slashes Wegovy/Ozempic revenue. New board and pipeline assets offer some…